Pal-AHK (Palmitoyl Ala-His-Lys): Lipidated Tripeptide Design, AHK-Cu Hair-Follicle Evidence, and the Limits of Structure-to-Function Extrapolation
1. Molecular Identity and Naming Discipline 1.1 What “PalAHK” Conventionally Describes The name PalAHK conventionally denotes a molecule composed of the AHK sequence—alanine, histidine, and lysine—bearing a palmitoyl group at its Nterminus. Palmitoyl refers to a 16carbon saturated fattyacidderived chain. Attaching this hydrophobic chain yields a lipopeptide that is chemically distinct from the unmodified, hydrophilic AHK tripeptide. It should be distinguished from AHKCu, in which the histidinecontaining peptide coordinates copper(II), and from PalGHK (Palmitoyl Tripeptide1), which has the different GlyHisLys sequence. The practical consequence is straightforward: an informal peptide name is not a complete characterization. A research material labeled PalAHK should be verified by a certificate of analysis, molecular mass, analytical purity, full structure, counterion or salt form, and a statement of whether any metal complex is present. Without that documentation, claims about “PalAHK” may inadvertently combine evidence for different materials under one label. 1.2 AHKCu versus PalAHK | Feature | PalAHK | AHKCu | Why the Distinction Matters | | | | | | | Core scaffold | Proposed AlaHisLys tripeptide with Nterminal C16 palmitoyl chain. | AlaHisLys tripeptide coordinated to Cu²⁺ [1]. | Lipidation and metal coordination are different chemical modifications. | | Direct peerreviewed study located? | No PalAHKspecific primary paper located in the reviewed source set. | Yes: hairfollicle and dermalpapilla experiments [1]. | Evidence for AHKCu cannot validate PalAHK. | | Chemistry expected to change | Higher hydrophobicity and formulation/partitioning behavior. | Copper coordination chemistry and redox/metal availability. | Different exposure, stability, aggregation, and targets are plausible. | | Human clinical evidence | No PalAHK human trial identified. | No clinical hairregrowth trial established by the cited 2007 study. | Exvivo activity is not clinical efficacy. | 2. What NTerminal Palmitoylation Can—and Cannot—Establish 2.1 Lipopeptide Design Logic Nterminal lipidation is a common strategy in peptide design because it can alter peptide–vehicle interactions, adsorption to lipidrich surfaces, aggregation, solubility, proteolytic accessibility, and local partitioning. In cosmeticpeptide development, a palmitoyl group is often intended to support formulation compatibility and localization within the stratumcorneum environment. These are design rationales rather than productspecific proof. Palmitoylation can also introduce formulation challenges, including altered dispersion, adsorption to packaging, and concentrationdependent aggregation. 2.2 What Remains Unknown for PalAHK No PalAHKspecific permeability, stability, bioavailability, receptorbinding, copperbinding, dermalpapilla, fibroblast, collagen, or human clinical dataset was identified in the reviewed peerreviewed sources. Therefore, it is not valid to state that PalAHK penetrates skin more effectively, is more stable, stimulates collagen, signals through a particular receptor, or promotes hair growth. Those are testable hypotheses, not established properties. Direct evidence would require chromatographic stability studies, skindistribution measurements, cellassay dose–response work, targetengagement experiments, and blinded human studies if any clinical claim were considered. “In the present study, the effects of LalanylLhistidylLlysineCu²⁺ (AHKCu) on human hair growth ex vivo and cultured dermal papilla cells were evaluated.” — Pyo et al., Archives of Pharmacal Research, 2007 [1] 3. Direct Related Evidence: AHKCu in HairFollicle Models 3.1 Human Follicles Ex Vivo and DermalPapilla Cells In Vitro Pyo and colleagues evaluated AHKCu at 10⁻¹² to 10⁻⁹ M in cultured human hair follicles and dermalpapilla cells. They reported increased human hairfollicle elongation ex vivo and increased dermalpapillacell proliferation in vitro [1]. Dermal papilla cells are specialized mesenchymal cells important to hairfollicle signaling, making the model relevant for basic hairbiology screening. Still, exvivo follicle elongation and culturedcell proliferation are intermediate research endpoints. They do not establish efficacy in androgenetic alopecia, durability of effect, optimal delivery, comparative effectiveness, or safety in people. 3.2 ApoptosisRelated Measurements At 10⁻⁹ M, AHKCu increased the Bcl2/Bax ratio and reduced cleaved caspase3 and PARP in dermalpapilla cells [1]. The reported reduction in apoptotic cells by flow cytometry was not statistically significant. That nuance matters: the study supports a hypothesis of altered survivalrelated signaling but does not prove that apoptosis suppression is the primary mechanism of follicle elongation. It also does not identify whether copper coordination, the AHK sequence, or their combined physicochemical properties were necessary for the effect. 3.3 Why AHKCu Results Cannot Be Assigned to PalAHK AHKCu and PalAHK differ in t
For research use only. Not for human consumption.